The study of HOLM et al. reported that SLC1A5 was involved in sphingolipid metabolism that contributes to genetic predisposition to type 1 diabetes, whereas there has been no direct evidence of the association between SLC1A5 and GDM risk (Holm et al., 2018). The gene discussed is SLC1A5; the disease is type 1 diabetes mellitus.